PetMed Express, Inc. (FRA:PQM)

PetMed Express Statistics

Total Valuation

PetMed Express has a market cap or net worth of EUR 53.52 million. The enterprise value is 31.23 million.

Market Cap	53.52M
Enterprise Value	31.23M

Important Dates

The last earnings date was Monday, February 2, 2026.

Earnings Date	Feb 2, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	21.37M
Shares Outstanding	n/a
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	+0.57%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	13.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.34
PB Ratio	1.92
P/TBV Ratio	2.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.57
EV / Sales	0.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.60

Financial Position

The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.02.

Current Ratio	0.89
Quick Ratio	0.52
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-45.98

Financial Efficiency

Return on equity (ROE) is -100.61% and return on invested capital (ROIC) is -531.54%.

Return on Equity (ROE)	-100.61%
Return on Assets (ROA)	-20.32%
Return on Invested Capital (ROIC)	-531.54%
Return on Capital Employed (ROCE)	-113.99%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	920,446
Profits Per Employee	-319,358
Employee Count	173
Asset Turnover	1.61
Inventory Turnover	11.29

Taxes

In the past 12 months, PetMed Express has paid 4.85 million in taxes.

Income Tax	4.85M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-41.08%
50-Day Moving Average	2.59
200-Day Moving Average	2.52
Relative Strength Index (RSI)	47.39
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.38

Income Statement

In the last 12 months, PetMed Express had revenue of EUR 159.24 million and -55.25 million in losses. Loss per share was -2.65.

Revenue	159.24M
Gross Profit	43.84M
Operating Income	-32.23M
Pretax Income	-50.40M
Net Income	-55.25M
EBITDA	-24.53M
EBIT	-32.23M
Loss Per Share	-2.65

Balance Sheet

The company has 22.92 million in cash and 555,308 in debt, with a net cash position of 22.37 million.

Cash & Cash Equivalents	22.92M
Total Debt	555,308
Net Cash	22.37M
Net Cash Per Share	n/a
Equity (Book Value)	27.91M
Book Value Per Share	1.31
Working Capital	-5.33M

Cash Flow

In the last 12 months, operating cash flow was -14.17 million and capital expenditures -5.35 million, giving a free cash flow of -19.52 million.

Operating Cash Flow	-14.17M
Capital Expenditures	-5.35M
Free Cash Flow	-19.52M
FCF Per Share	n/a

Margins

Gross margin is 27.53%, with operating and profit margins of -20.24% and -34.70%.

Gross Margin	27.53%
Operating Margin	-20.24%
Pretax Margin	-31.65%
Profit Margin	-34.70%
EBITDA Margin	-15.41%
EBIT Margin	-20.24%
FCF Margin	n/a

Dividends & Yields

PetMed Express does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.13%
Shareholder Yield	0.13%
Earnings Yield	-103.23%
FCF Yield	-36.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PetMed Express has an Altman Z-Score of 1.6 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.6
Piotroski F-Score	2